MedPath

Does have autologous blood withdrawal pre-operative with and without sequestration, effect on the usage of allogeneic bloodproducts during and after heartsurgery.

Completed
Conditions
Need for blood transfusion during and after open heart surgery
10007593
Registration Number
NL-OMON33597
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
102
Inclusion Criteria

Adults age >= 18 year, undergoing openheartsurgery for CABG and or valve surgery
BSA > 170 dm2
Hemoglobin/Hematocrit >= 0,20 L/L

Exclusion Criteria

Pre-operative Total Trombocytes < 120 x 109/L
Pre-operative increased liver enzymes: ASAT, ALAT, AF >= 2,5 x ULN
NYHA Class III and IV
Severe impaired renal function: Creatinine > 120 umol/l
Re operation
COPD

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Is there a decrease in use of allogeneic blood products in the sequestration<br /><br>group?<br /><br></p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Is there a decrease of blood loss in the sequestration group in regards to the<br /><br>blood loss of the other two groups?</p><br>
© Copyright 2025. All Rights Reserved by MedPath